201 related articles for article (PubMed ID: 16638566)
21. Generation of synthetic severe acute respiratory syndrome coronavirus pseudoparticles: implications for assembly and vaccine production.
Huang Y; Yang ZY; Kong WP; Nabel GJ
J Virol; 2004 Nov; 78(22):12557-65. PubMed ID: 15507643
[TBL] [Abstract][Full Text] [Related]
22. Recent developments in the virology and antiviral research of severe acute respiratory syndrome coronavirus.
Yeung KS; Meanwell NA
Infect Disord Drug Targets; 2007 Mar; 7(1):29-41. PubMed ID: 17346209
[TBL] [Abstract][Full Text] [Related]
23. The human severe acute respiratory syndrome coronavirus (SARS-CoV) 8b protein is distinct from its counterpart in animal SARS-CoV and down-regulates the expression of the envelope protein in infected cells.
Keng CT; Choi YW; Welkers MR; Chan DZ; Shen S; Gee Lim S; Hong W; Tan YJ
Virology; 2006 Oct; 354(1):132-42. PubMed ID: 16876844
[TBL] [Abstract][Full Text] [Related]
24. Understanding the accessory viral proteins unique to the severe acute respiratory syndrome (SARS) coronavirus.
Tan YJ; Lim SG; Hong W
Antiviral Res; 2006 Nov; 72(2):78-88. PubMed ID: 16820226
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of advanced reverse transcription-PCR assays and an alternative PCR target region for detection of severe acute respiratory syndrome-associated coronavirus.
Drosten C; Chiu LL; Panning M; Leong HN; Preiser W; Tam JS; Günther S; Kramme S; Emmerich P; Ng WL; Schmitz H; Koay ES
J Clin Microbiol; 2004 May; 42(5):2043-7. PubMed ID: 15131168
[TBL] [Abstract][Full Text] [Related]
26. Molecular biology of severe acute respiratory syndrome coronavirus.
Ziebuhr J
Curr Opin Microbiol; 2004 Aug; 7(4):412-9. PubMed ID: 15358261
[TBL] [Abstract][Full Text] [Related]
27. SARS coronavirus replicase proteins in pathogenesis.
Graham RL; Sparks JS; Eckerle LD; Sims AC; Denison MR
Virus Res; 2008 Apr; 133(1):88-100. PubMed ID: 17397959
[TBL] [Abstract][Full Text] [Related]
28. Severe acute respiratory syndrome coronavirus replication inhibitor that interferes with the nucleic acid unwinding of the viral helicase.
Adedeji AO; Singh K; Calcaterra NE; DeDiego ML; Enjuanes L; Weiss S; Sarafianos SG
Antimicrob Agents Chemother; 2012 Sep; 56(9):4718-28. PubMed ID: 22733076
[TBL] [Abstract][Full Text] [Related]
29. Severe acute respiratory syndrome coronavirus group-specific open reading frames encode nonessential functions for replication in cell cultures and mice.
Yount B; Roberts RS; Sims AC; Deming D; Frieman MB; Sparks J; Denison MR; Davis N; Baric RS
J Virol; 2005 Dec; 79(23):14909-22. PubMed ID: 16282490
[TBL] [Abstract][Full Text] [Related]
30. SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology.
Ogando NS; Dalebout TJ; Zevenhoven-Dobbe JC; Limpens RWAL; van der Meer Y; Caly L; Druce J; de Vries JJC; Kikkert M; Bárcena M; Sidorov I; Snijder EJ
J Gen Virol; 2020 Sep; 101(9):925-940. PubMed ID: 32568027
[TBL] [Abstract][Full Text] [Related]
31. Severe acute respiratory syndrome (SARS) S protein production in plants: development of recombinant vaccine.
Pogrebnyak N; Golovkin M; Andrianov V; Spitsin S; Smirnov Y; Egolf R; Koprowski H
Proc Natl Acad Sci U S A; 2005 Jun; 102(25):9062-7. PubMed ID: 15956182
[TBL] [Abstract][Full Text] [Related]
32. Multiple gene targeting siRNAs for down regulation of Immediate Early-2 (Ie2) and DNA polymerase genes mediated inhibition of novel rat Cytomegalovirus (strain All-03).
Balakrishnan KN; Abdullah AA; Bala JA; Jesse FFA; Abdullah CAC; Noordin MM; Mohd-Azmi ML
Virol J; 2020 Oct; 17(1):164. PubMed ID: 33109247
[TBL] [Abstract][Full Text] [Related]
33. Identification of severe acute respiratory syndrome coronavirus replicase products and characterization of papain-like protease activity.
Harcourt BH; Jukneliene D; Kanjanahaluethai A; Bechill J; Severson KM; Smith CM; Rota PA; Baker SC
J Virol; 2004 Dec; 78(24):13600-12. PubMed ID: 15564471
[TBL] [Abstract][Full Text] [Related]
34. A single tyrosine in the severe acute respiratory syndrome coronavirus membrane protein cytoplasmic tail is important for efficient interaction with spike protein.
McBride CE; Machamer CE
J Virol; 2010 Feb; 84(4):1891-901. PubMed ID: 20007283
[TBL] [Abstract][Full Text] [Related]
35. Design and validation of small interfering RNA on respiratory syncytial virus M2-2 gene: A potential approach in RNA interference on viral replication.
Chin VK; Atika Aziz NA; Hudu SA; Harmal NS; Syahrilnizam A; Jalilian FA; Zamberi S
J Virol Methods; 2016 Oct; 236():117-125. PubMed ID: 27432115
[TBL] [Abstract][Full Text] [Related]
36. Silencing SARS-CoV Spike protein expression in cultured cells by RNA interference.
Zhang Y; Li T; Fu L; Yu C; Li Y; Xu X; Wang Y; Ning H; Zhang S; Chen W; Babiuk LA; Chang Z
FEBS Lett; 2004 Feb; 560(1-3):141-6. PubMed ID: 14988013
[TBL] [Abstract][Full Text] [Related]
37. Susceptibility of pigs and chickens to SARS coronavirus.
Weingartl HM; Copps J; Drebot MA; Marszal P; Smith G; Gren J; Andova M; Pasick J; Kitching P; Czub M
Emerg Infect Dis; 2004 Feb; 10(2):179-84. PubMed ID: 15030680
[TBL] [Abstract][Full Text] [Related]
38. Small interfering RNA effectively inhibits the expression of SARS coronavirus membrane gene at two novel targeting sites.
Wang Y; Cao YL; Yang F; Zhang Y; Wang SH; Liu L
Molecules; 2010 Oct; 15(10):7197-207. PubMed ID: 20956884
[TBL] [Abstract][Full Text] [Related]
39. Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins.
Wang SF; Tseng SP; Yen CH; Yang JY; Tsao CH; Shen CW; Chen KH; Liu FT; Liu WT; Chen YM; Huang JC
Biochem Biophys Res Commun; 2014 Aug; 451(2):208-14. PubMed ID: 25073113
[TBL] [Abstract][Full Text] [Related]
40. An overall picture of SARS coronavirus (SARS-CoV) genome-encoded major proteins: structures, functions and drug development.
Chen S; Luo H; Chen L; Chen J; Shen J; Zhu W; Chen K; Shen X; Jiang H
Curr Pharm Des; 2006; 12(35):4539-53. PubMed ID: 17168760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
